Aspira Women's Health Signs Laboratory Services Agreement with Mayo Clinic Laboratories
I'm PortAI, I can summarize articles.
Aspira Women's Health Inc. has signed a Laboratory Services Agreement with Mayo Clinic Laboratories, effective December 16, 2025. Aspira will provide reference laboratory testing services, including Ova1Plus and OvaWatch tests, to Mayo on a non-exclusive basis. The agreement has a five-year term with automatic renewals and includes provisions for termination, confidentiality, and compliance with healthcare laws. Mayo will manage ordering, delivery, and billing, while Aspira will invoice Mayo for services. Fees remain fixed unless adjusted mutually.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments